All News #Library
Biotech
CREATE Medicines Doses First Patient in Phase 1/2 Study of MT-304
23 Apr 2026 //
PR NEWSWIRE
CREATE Medicines Shows B-Cell Depletion in Nonhuman Primates
02 Feb 2026 //
PR NEWSWIRE

Market Place
Sourcing Support